Triclosan-Coated Sutures Now Recommended By World Health Organization
Ethicon Plus Sutures are the only globally available sutures coated with triclosan that inhibit colonization of the suture by bacteria commonly associated with Surgical Site Infections, the most common type of healthcare associated infection.
SOMERVILLE, N.J., Nov. 4, 2016 /PRNewswire-USNewswire/ -- Ethicon*, a trusted leader in suture technology, announced today that triclosan-coated sutures received a recommendation in the new "Global Guidelines for the Prevention of Surgical Site Infections (SSI)", the first-ever Global guidelines on SSIs released by the World Health Organization (WHO). Categorized as a conditional recommendation, the use of triclosan coated sutures is now supported by the WHO based on moderate-quality of evidence.** According to the new WHO Guidelines, "the panel suggests the use of triclosan-coated sutures for the purpose of reducing the risk of surgical site infection (SSI), independent of the type of surgery." Suture selection provides an important opportunity to address a key risk factor for infection - bacterial colonization of the suture. Ethicon Plus Sutures are the only globally available sutures coated with triclosan that inhibit colonization of the suture by bacteria commonly associated with SSIs, including S. aureus, S. epidermidis, MRSA, MRSE, E. coli +, and K. pneumonia +.[i] ,[ii],[iii] To that end, Ethicon offers a comprehensive range of antibacterial sutures, including Coated VICRYL® Plus Antibacterial (polyglactin 910); MONOCRYL® Plus Antibacterial (poliglecaprone 25); PDS® Plus Antibacterial (polydioxanone); STRATAFIX™ Spiral PDS Plus Knotless Tissue Control Device; STRATAFIX™ Spiral Monocryl Plus Knotless Tissue Control Device; and STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device. "Several independent studies have found that triclosan-coated sutures reduce the risk of SSI across many types of surgery," said Professor David Leaper, Emeritus Professor of Surgery University of Newcastle upon Tyne, Professor of Clinical Sciences University of Huddersfield, United Kingdom. "Taken together with other evidence-based interventions, Ethicon Plus Sutures may help reduce hospital costs associated with infections, including longer length of stay or readmission." Ethicon first innovated the triclosan coated suture with the introduction of Coated VICRYL® Plus Antibacterial (polyglactin 910) suture in 2003. SSIs are among the most common healthcare-associated infections (HAI) worldwide; they increase morbidity and mortality in surgical patients and represent an economic burden to healthcare systems.[iv] In fact, SSIs are the leading infection in the general patient population in countries with limited resources, affecting up to two thirds of operated patients and with a frequency up to nine times higher than in developed countries. [v]